Wen‐Ho Chang

National Cheng Kung University Hospital — Taiwan

Medicine · Health Sciences

25h-index2.5kcitations65works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(51), Bipolar Disorder and Treatment(23), Treatment of Major Depression(14), Epilepsy research and treatment(13), Electroconvulsive Therapy Studies(12)

Publications65 total

396. THE ADVERSE EXPERIENCES, SOCIAL SUPPORT, AND NEUROCHEMICAL ALTERATIONS IN BIPOLAR DISORDER: A FOCUS ON HISTORY OF PSYCHOTIC FEATURES
The International Journal of Neuropsychopharmacology·2025Open Access
445. DISTINCTIVE ASSOCIATION PATTERNS BETWEEN TOPOLOGICAL PROPERTIES OF BRAIN STRUCTURAL NETWORKS AND SOCIAL COGNITION IN EUTHYMIC BIPOLAR DISORDER
The International Journal of Neuropsychopharmacology·2025Open Access
Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychotics
Psychopharmacology·2008· 4 cited
Prefrontal executive function and D<b><sub>1</sub></b>, D<b><sub>3</sub></b>, 5-HT<b><sub>2A</sub></b> and 5-HT<b><sub>6</sub></b> receptor gene variations in healthy adults
Journal of Psychiatry and Neuroscience·2008· 1 cited
Risperidone-related Weight Gain
Journal of Clinical Psychopharmacology·2006· 148 cited
Regular-Dose Risperidone on QTc Intervals
Journal of Clinical Psychopharmacology·2005· 13 cited
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
Pharmacogenomics·2005· 53 cited
Dopamine D3 Receptor Ser9Gly Polymorphism and Risperidone Response
Journal of Clinical Psychopharmacology·2005· 77 cited
Dose‐Dependent Alternations in the Pharmacokinetics of Olanzapine During Coadministration of Fluvoxamine in Patients With Schizophrenia
The Journal of Clinical Pharmacology·2004· 29 cited
Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
The International Journal of Neuropsychopharmacology·2004· 99 cited
Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances
The Journal of Clinical Psychiatry·2004· 134 cited
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
Psychopharmacology·2004· 15 cited
Refining pharmacogenetic research in schizophrenia: Control for patient‐related variables
Drug Development Research·2003· 3 citedOpen Access
Genetic Factors Influencing Cognitive Function
Acta Neurologica Taiwanica·2003
Schizophrenia: Attention Deficits and the NMDA Hypothesis
慈濟醫學雜誌·2003
Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia
The Journal of Clinical Psychiatry·2003· 55 cited
Dosing Strategies of Clozapine-Fluvoxamine Cotreatment
Journal of Clinical Psychopharmacology·2002· 6 cited
Effects of Olanzapine Plasma Concentrations on Depressive Symptoms in Schizophrenia: A Pilot Study
Journal of Clinical Psychopharmacology·2002· 20 cited
Association of Risperidone Treatment Response With a Polymorphism in the 5-HT<sub>2A</sub> Receptor Gene
American Journal of Psychiatry·2002· 139 cited
Fluvoxamine-Clozapine Interaction: Time-dependent?
Journal of Clinical Psychopharmacology·2002· 2 cited
page 1 of 4Next →

Frequent Co-authors

Hsien‐Yuan Lane(32), Michael W. Jann(15), Yue‐Cune Chang(9), Shih‐Ku Lin(8), Chih‐Chiang Chiu(5), Mong‐Liang Lu(5), Ming‐Chyi Huang(5), Hsien‐Yuan Lane(4), Wei-Herng Hu(4), Sue-Hong Lee(4), Mika Scheinin(3), Yi‐Ching Liu(3), Muh‐Hwan Su(3), Fu‐Chuan Wei(3), Y. W. Francis Lam(3), Markku Linnoila(2), C.‐H. Lu(2), Kun‐Po Chen(2), Cheng-Chun Lee(2), Chiung-Hsien Huang(2)